“…Despite this, PHBs have been subject to criticism that includes contestation about the robustness of the evidence (Davidson, Baxter, Glendinning, & Irvine, 2013;Limb, 2016) claims that clinician time will be spent on complex, expensive bureaucratic processes (Slasberg, Watson, Beresford, & Schofield, 2014); possible inefficiency arising from poor patient choices and fraud (Iacobucci, 2015); 'wasted' money on non-evidence-based therapies (Sheppard, 2015) being ideologically motivated and breaking with the NHS 'free at the point of delivery' ethos (Beresford & Slasberg, 2018;Hewitt-Taylor, 2008); and paving the way to a private insurance-based system (Scott-Samuel, 2015). Finally, the extension of PHBs is being undertaken at a time of reduced local authority resources, NHS restructuring and budgetary constraints-which has implications for their delivery (Williams & Dickinson, 2016).…”